Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
Keytruda, Padcev cut risk of death by 50% in MIBC patient subset
The perioperative PD-1/ADC combo also significantly improved event-free survival by 60% versus surgery alone.
Angus Liuu
Oct 18, 2025 10:30am
AZ's Imfinzi looks set up for another bladder cancer expansion
Oct 17, 2025 8:10am
Pfizer scores again in HER2-positive breast cancer
Oct 14, 2025 12:33pm
UPDATED: Pfizer offers US drug price concessions in MFN push
Sep 30, 2025 1:07pm
ACIP narrowly votes against COVID vaccine prescriptions
Sep 19, 2025 5:22pm
Inside the commercial growing pains of hemophilia gene therapies
Sep 12, 2025 10:00am
